Tumour necrosis factor alpha and interleukin 2 in normal and infected human seminal fluid

The presence of cytokines such as the tumour necrosis factoralpha (TNF) and interleukin 2 (IL2) in human spermatozoa isstill to be defined. The aim of this study was to measure theconcentration of both soluble factors in seminal fluid. Datafrom normal semen samples (n = 24) confirmed the presence ofIL2 (258 ± 84 fmol/ml corresponding to 953 ± 369fmol/total volume of ejaculate) and TNFa (62.2 ± 16.4fmol/ml corresponding to 231.3 ± 86 fmol/total volumeof ejaculate). A significant positive correlation (r = 0.59;P < 0.01) was observed between the TNFa and the IL2 concentrations.The concentrations of these cytokines were not related to spermparameters. In contrast, IL2 concentrations (196.9 ±60.4 fmol/ml; 686.2 ± 236.7 fmol/total volume of ejaculate)evaluated in 16 seminal fluids with identified bacterial agentswere lower than in the control group, whereas TNF concentrations(68.6 ± 12.3 fmol/ml; 241.3 ± 78.9 fmol/totalvolume of ejaculate) were not significantly different from thecontrols. Further studies are needed to determine the potentialrole of these cytokines in the physiology of semen and theirusefulness as indicators of reproductive pathology.     

Stability of Interleukin 1β (IL-1β) in Aqueous Solution: Analytical Methods,Kinetics, Products,and Solution Formulation Implications

The thermal stability of IL-1 in aqueous solution as a function of temperature (5–60°C), pH (2–9), buffer (acetate, citrate, tris, and phosphate), and cyroprotectants (sugars, HSA) was investigated in this study. The analytical methodologies included RP-HPLC, SEC, ELISA, IEF-PAGE, SDS-PAGE, and bioassay. The degradation and inactivation of IL-1 at or above 39°C were attributed to autoxidation of the two cysteine residues in the denatured protein, followed by hydrophobic/covalent aggregation and precipitation. At or below 30°C, IEF- and SDS-PAGE results suggest a possible deamidation reaction. The difference in mechanism of degradation precludes the prediction of formulation shelf life from accelerated temperature data. Nonetheless, the good stability observed at 5°C suggests that a solution formulation may be feasible for IL-1.     

Immunocytochemical analysis of interferon-1β production by human monocytes

All-Union Research Institute of Highly Pure Biological Preparations, Leningrad. (Presented by Academician of the Academy of Medical Sciences of the USSR V. D. Belyakov). Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 112, No. 9, pp. 278–280, September, 1991.     

脑源性白介素的研究进展

传统观点认为白介素是由免疫细胞产生的 ,然而 ,许多研究资料表明 ,神经元和神经胶质细胞也能够产生和分泌白介素 ,即脑源性白介素。脑源性白介素可与中枢神经系统多种神经递质相互作用 ,影响动物的行为、学习记忆 ,并与早老性痴呆、抑郁症等疾病相关。深入研究脑源性白介素对理解许多疾病的病理生理进程有积极意义     

异维A酸治疗尖锐湿疣对白细胞介素-2、可溶性白细胞介素-2受体影响

目的 :观察异维A酸治疗尖锐湿疣对血清白细胞介素 2 (IL 2 ) ,可溶性白细胞介素 2受体(sIL 2R)的变化 ,以探讨异维A酸治疗尖锐湿疣的作用机制。方法 :3 2例尖锐湿疣病人 ,初发 1 3例 ,复发 1 9例 ,给异维A酸胶丸 1 0mg,po,tid或bid ,随访 3mo ,治疗前及治疗后mo 4查血清sIL 2R ,IL 2。结果 :痊愈 2 4例 (75 % ) ,显效 3例 ,有效 2例 ,无效 3例 (9% ) ;血清sIL 2R初发病人治疗前为(2 0 1±s 1 2 1 ) pmol·L-1,治疗后mo 4为 (1 93±1 3 2 ) pmol·L-1,P <0 .0 5 ;血清sIL 2R复发病人治疗前为 (693± 1 2 1 )pmol·L-1,治疗后mo 4为 (5 1 9± 1 0 3 ) pmol·L-1,P <0 .0 1 ;血清IL 2初发病人治疗前 (7.0± 1 .2 ) μg·L-1,治疗mo 4为 (7.2± 1 .2 )μg·L-1,P <0 .0 1 ;血清IL 2复发病人治疗前 (6±3 ) μg·L-1,治疗后mo 4为 (8.5± 2 .7) μg·L-1,P<0 .0 1。结论 :异维A酸通过调节免疫及其他多种机制达到治疗尖锐湿疣的作用     

原发性肝癌患者介入治疗前后血清TNF-α、SIL-2R水平检测的临床意义

目的　分析 36例原发性肝癌患者介入治疗前后血清 TNF-α和 SIL - 2 R含量的变化。方法　采用放射免疫法测定血清 TNF- α含量 ,EL ISA法检测 SIL- 2 R含量 ,并以 35名正常健康人作对照。结果　介入治疗前血 TNF- α和 SIL- 2 R含量明显地高于正常人组水平 ( P<0 .0 1) ,介入治疗后 6个月复发者 TNF- α、SIL- 2 R水平持续异常 ,未复发者 TNF-α、SIL - 2 R水平恢复正常。结论　观察患者的免疫功能变化对原发性肝癌患者的病情和预后密切相关     

Quantitative Detection of Interleukin 8 Gene Expression in Lung Cancer by Real-time Polymerase Chain Reaction

Objective To develop a method for absolute quantification of interleukin 8 (IL—8) mRNA by using real-time polymerase chain reaction (PCR). Methods The IL —8 mRNA and protein expression in 2 human lung cancer cell lines, H460 and A549, were evaluated by real-time PCR and ELISA. The IL-8 mRNA expression in 9 cases of normal lung tissue and 44 cases of non-small cell lung cancer (NSCLC) were examined. Results The IL—8 mRNA copy number in a given sample can be measured by real-time PCR. The gene expression of IL—8 is correlated with its protein secretion. The normalized value of IL—8 expression was 4.87±1.69 (copies/ 10⁴ GAPDH copies) in normal lung tissue and 17.04 ±23.96 in NSCLC, respectively. The difference between these two groups is statistically significant (P=0.002). Using 9.74 and 19.48 as cut-off points for positive expression and overexpression of IL—8, 52.3%(23/44cases) of NSCLC were found to express an increased level of IL-8, among which 29.5% (13/ 44cases) were defined as positive expression and 22.7%(10/44cases) as overexpression. Statistical analysis indicated that IL—8 overexpression was significantly increased in female cancers, squamous carcinoma, and in late stages of disease (P<0.05). Conclusion The IL—8 gene expression can be determined by a real-time PCR technique. IL -8 overexpression is correlated with gender, histopathology and stages of the disease.     

变应性鼻炎患者可溶性白细胞介素-2受体的测定

为探讨可溶性白细胞介素－２受体（ｓｏｌｕｂｌｅｉｎｔｅｒｌｅｕｋｉｎ２ｒｅｃｅｐｔｏｒ，ＳＩＬ－２Ｒ）在变应性鼻炎中的作用机理，采用双抗体夹心酶联免疫吸附测定（ＥＬＩＳＡ）法测定３９例变应性鼻炎患者、１９例慢性鼻炎患者和１５例健康人血清及鼻分泌物ＳＩＬ－２Ｒ水平。结果发现变应性鼻炎患者血清ＳＩＬ－２Ｒ水平高于慢性鼻炎患者及健康人（Ｐ＜０．００１）。提示ＳＩＬ－２Ｒ在变应性鼻炎的发病中起重要作用     

哮喘患儿血白细胞介素-2、10、13检测的临床意义

目的　探讨哮喘患儿外周血白细胞介素 2 (IL 2 )、IL 10、IL 13的变化及其在哮喘发病机制中的作用。方法　用ELISA双抗体夹心法测定 16例哮喘患儿及 10例正常儿童血浆IL 2、IL 10、IL 13的含量。结果　哮喘组血浆IL 2、IL 13水平均明显高于正常对照组 ,IL 10水平明显低于正常对照组 (P均 <0 .0 5)。结论　IL 2、IL 10、IL 13等细胞因子参与儿童哮喘发病的病理生理过程 ,可作为病情变化的监测指标     

充血性心力衰竭患儿血清白细胞介素-18和淋巴细胞CD54变化

目的探讨IL-18和CDs4在小儿充血性心力衰竭（CFIF）发病中的作用，及其对z],JLCFIF的诊断价值。方法CFIF患儿52例，心功能按修订的Ross和Reithman评分系统。心功能Ⅱ级（3～6分）18例、Ⅲ级（7～9分）17例，Ⅳ级（10～12分）17例。原发疾病为扩张性心肌病、心内膜弹力纤维增生症及先天性心脏病等。对照组15例为上呼吸道感染患儿。血清IL-18水平用ELISA法进行测定，采用流式细胞术检测外周血淋巴细胞CDs4表达。结果CFIF患儿血清IL-18及CDs4均显著增高（P均〈0．001），且随CFIF加重渐增加，治疗后两者均较治疗前明显降低（P均〈0．05）；且两者在心肌病组、先天性心脏病组及其他病组3组间比较差异无显著性（P均〉0．05），但均显著高于对照组（P均〈0．01）。结论IL-18和CDs4可能参与小儿CFIF发生发展。可以作为评价CHF严重程度的生物化学标记；CFIF作为一种临床综合征，无论最初病因是否相同，免疫反应可能都具有某些共同特征。